Description of patient-level access to OAT during admission for the opioid use disorder cohort and the stratifications, OAT and non-OAT groups
| VARIABLE | TOTAL COHORT (N = 1910), N (%) | NON-OAT GROUP (N = 1522), N (%)* | OAT GROUP (N = 388), N (%)* |
|---|---|---|---|
| Entered program that does not permit OAT | 902 (47.2) | 882 (58.0) | 20 (5.2) |
| Entered program that permits OAT | 1008 (52.8) | 640 (42.1) | 368 (94.9) |
| • But does not prescribe or dispense on-site | 761 (75.5) | 500 (78.1) | 261 (70.9) |
| • And only prescribes on-site | 86 (8.5) | 45 (7.0) | 41 (11.1) |
| • And only dispenses on-site | 131 (13.0) | 82 (12.8) | 49 (13.3) |
| • And prescribes and dispenses on-site | 30 (3.0) | 13 (2.0) | 17 (4.6) |
OAT—opioid agonist therapy.
↵* Not all percentages add to 100% owing to rounding.